medigraphic.com
ISSN 1561-3070 (Electronic)

2022, Number 2

<< Back Next >>

Rev Cub Oftal 2022; 35 (2)

Nonorganic loss of color vision

Marrero OW, Mayea DDY

Language: Spanish
References: 15
Page: 1-7
PDF size: 240.35 Kb.


ABSTRACT

Non-organic loss of vision or functional loss is a disorder in which certain visual symptomatology is present, without any cause that could justify it. We present a case of a 16-year-old female adolescent patient, white skin color, with ocular history of congenital right palpebral ptosis and bad eating habits. Her reason for consultation was loss of color vision not initially detected; then, due to her insistence, we began to notice a progressive and incongruent decrease in color vision, with normal visual functional parameters, defects in non-reproducible computerized visual fields and normal visual electrophysiology tests, with total recovery of this defect without any specific therapeutic behavior. Non-organic vision loss refers to any visual defect in which no alteration of the structures between the cornea and the occipital cerebral cortex is demonstrated. Disorders of the afferent pathway constitute the most frequent manifestation. There may be unilateral or bilateral decreased vision, visual field impairment, or both. Color vision is usually abnormal, but rarely, it is the reason for consultation. Psychogenic origin is common in children and is more frequent in women than in men. Acquired color vision deficits occur as a consequence of an ocular pathology, intracranial injury or excessive use of medication and are usually accompanied by variable loss of visual acuity.


REFERENCES

  1. Miller Neil R, Newman Nancy J. Nonorganic Disease. Neuro-Ophthalmologic Manifestations of Nonorganic Disease. Walsh & Hoyt's Clinical Neuro-Ophthalmology. 2005. p. 1316-28.

  2. Rivas García, KH. Pérdida visual funcional. De la histeria visual a los simuladores. Diagnóstico diferencial. BS thesis. Universitat Politècnica de Catalunya, 2021. Disponible en: http://hdl.handle.net/2117/3426012.

  3. Muñoz-Hernández AM, García-Catalán R, Santos-Bueso E, López-Abad C, Gil-De-Bernabé JG, Díaz-Valle D, et al. Simulación en oftalmología. Arch Soc Esp Oftalmol. 2011 [acceso 10/05/2021];86(10):320-326. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0365-66912011001000003&lng=pt3.

  4. Griffiths PG, Eddyshaw D. Medically unexplained visual loss in adult patients. Eye (Lond). 2004;18(9):917-22. DOI: https://doi.org/10.1038/sj.eye.67013674.

  5. Toldo I, Pinello L, Suppiej A, Ermani M, Cermakova I, Zanin E, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30(1):26-30. DOI: https://doi.org/10.1097/WNO.0b013e3181c252b95.

  6. Somers A, Casteels K, Van Roie E, Spileers W, Casteels I. Non-organic visual loss in children: prospective and retrospective analysis of associated psychosocial problems and stress factors. Acta Ophthalmol. 2016 Aug;94(5):e312-6. DOI: https://doi.org/10.1111/aos.128486.

  7. Chacko JG, McClard CK. Functional Visual Loss. American Academy of Ophthalmology 2020 [acceso 10/05/2021]. Disponible en: https://eyewiki.aao.org/Functional_Visual_Loss7.

  8. Miller NR. Functional neuro-ophthalmology. Handb Clin Neurol. 2011;102:493-513. DOI: https://doi.org/10.1016/B978-0-444-52903-9.00024-88.

  9. Alozai Uu, McPherson PK. Malingering. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2020 [acceso 27/06/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK5078379.

  10. McBain VA, Robson AG, Hogg CR, Holder GE. Assessment of patients with suspected non-organic visual loss using pattern appearance visual evoked potentials. Graefes Arch Clin Exp Ophthalmol. 2007;245(4):502-10. DOI: https://doi.org/10.1007/s00417-006-0431-210.

  11. Da Silveira Cespedes M, Biberg-Salum TG, Canavarros Monteiro R. Prevalence of Dyschromatopsias in the Academic Community of a Medicine School Course. J Health Sci. 2021;23(1):30-4. DOI: https://doi.org/10.17921/2447-8938.2021v23n1p30-3411.

  12. F. Rigaudière J, Leid F, Viénot JF, Gargasson L. Comprendre et tester les déficiences de la vision des couleurs de l'enfant, en pratique. J Fr. Ophtalmol. 2006.

  13. Piro A, Tagarelli A, Nicoletti G, Chiriaco C, Novellino F, Quattrone A. Color vision as a biological marker able to differentiate two phenotypically similar neurological diseases. Neurol Sci. 2018;39(5):951-52. DOI: https://doi.org/10.1007/s10072-017-3219-813.

  14. Piro A, Tagarelli A, Nicoletti G, Scannapieco S, Polidoro S, Valentino P, et al. Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease. Int Ophthalmol. 2019;39(3):671-76. DOI: https://doi.org/10.1007/s10792-018-0838-x14.

  15. Birch J. Pass rates for the Farnsworth D15 colour vision test. Ophthalmic Physiol Opt. 2008;28(3):259-64. DOI: https://doi.org/10.1111/j.1475-1313.2008.00566.x15.




2020     |     www.medigraphic.com